Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Zhang, Wei ^a   Zhu, Jing ^a   Bai, Jing ^a   Jiang, Hui ^a   Liu, Fangli ^a   Liu, An ^a   Liu, Peng ^a   Ji, Guohua ^a   Guan, Rongwei ^a   Sun, Donglin ^a   Ji, Wei ^a   Yu, Yang ^a   Jin, Yan ^a   Meng, Xiangning ^a   Fu, Songbin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HYBRID PROTEIN; MESSENGER RNA;

AFFINITY CHROMATOGRAPHY; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE; GENE INACTIVATION; GENE LOCUS; GENE THERAPY; GENETIC TRANSFECTION; GENETIC VARIABILITY; GROWTH CURVE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; LUNG CANCER; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; ALTERNATIVE RNA SPLICING; CELL CYCLE; CELL PROLIFERATION; ENZYME IMMUNOASSAY; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE; WESTERN BLOTTING;

ALTERNATIVE SPLICING; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FLOW CYTOMETRY; GENETIC VARIATION; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 77953592117     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-74     Document Type: Article

References (29)

1. Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer. RJ Michalides, J Clin Pathol 1999 52 8 555 568 10.1136/jcp.52.8.555 10645224
2. Cell cycle and cancer. MT Park SJ Lee, J Biochem Mol Biol 2003 36 1 60 65 12542976
3. INK4a/ARF: a multifunctional tumor suppressor locus. NE Sharpless, Mutat Res 2005 576 1-2 22 38 15878778
4. Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus. KD Robertson PA Jones, Oncogene 1999 18 26 3810 3820 10.1038/sj.onc.1202737 10445844
5. Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma. GL Wang KW Lo KS Tsang NY Chung YS Tsang ST Cheung JC Lee DP Huang, Br J Cancer 1999 81 7 1122 1126 10.1038/sj.bjc.6690818 10584871
6. The INK4A/ARF locus: role in cell cycle control and apoptosis and implications for glioma growth. SM Ivanchuk S Mondal PB Dirks JT Rutka, J Neurooncol 2001 51 3 219 229 10.1023/A:1010632309113 11407594
7. Role of p14(ARF) in replicative and induced senescence of human fibroblasts. W Wei RM Hemmer JM Sedivy, Mol Cell Biol 2001 21 20 6748 6757 10.1128/MCB.21.20.6748-6757.2001 11564860
8. The emerging p53 gene family. WG Kaelin Jr, J Natl Cancer Inst 1999 91 7 594 598 10.1093/jnci/91.7.594 10203277
9. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. K Kawamoto H Enokida T Gotanda H Kubo K Nishiyama M Kawahara M Nakagawa, Biochem Biophys Res Commun 2006 339 3 790 796 10.1016/j.bbrc.2005.11. 072 16316628
10. Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer. M Lee W Sup Han O Kyoung Kim S Hee Sung M Sun Cho SN Lee H Koo, Pathol Res Pract 2006 202 6 415 424 10.1016/j.prp.2005.11.011 16675157
11. Mutational analysis of genes p14ARF, p15INK4b, p16INK4a, and PTEN in human nervous system tumors. LO Almeida AC Custodio JJ Araujo JA Rey JR Almeida MJ Santos CA Clara C Casartelli, Genet Mol Res 2008 7 2 451 459 10.4238/vol7-2gmr445 18551412
12. Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers. A Pacifico LH Goldberg K Peris S Chimenti G Leone HN Ananthaswamy, Br J Dermatol 2008 158 2 291 297 18070208
13. A cell cycle regulator potentially involved in genesis of many tumor types. A Kamb NA Gruis J Weaver-Feldhaus Q Liu K Harshman SV Tavtigian E Stockert RS Day BE Johnson MH Skolnick, Science 1994 264 5157 436 440 10.1126/science.8153634 8153634
14. Pathogenetic and biologic significance of TP14ARF alterations in nonsmall cell lung carcinoma. MJ Park K Shimizu T Nakano YB Park T Kohno M Tani J Yokota, Cancer Genet Cytogenet 2003 141 1 5 13 10.1016/S0165-4608(02)00645-3 12581892
15. Effects of exogenous p16(ink4a) gene on biological behaviors of human lung cancer cells. X Zhang Y Jin X Tao M Bai, J Huazhong Univ Sci Technolog Med Sci 2007 27 1 37 40 10.1007/s11596-007-0111-4 17393105
16. Cisplatin-induced senescence and growth inhibition in human non-small cell lung cancer cells with ectopic transfer of p16INK4a. K Fang CC Chiu CH Li YT Chang HT Hwang, Oncol Res 2007 16 10 479 488 10.3727/096504007783338331 18196872
17. The co-transfection of p16(INK4a) and p14(ARF) genes into human lung cancer cell line A549 and the effects on cell growth and chemosensitivity. QC Xie YD Hu LL Wang ZT Chen XW Diao ZX Wang HJ Guan B Zhu JG Sun YZ Duan FL Chen WQ Nian, Colloids Surf B Biointerfaces 2005 46 3 188 196 10.1016/j.colsurfb. 2005.10.006 16337111
18. Recurrent patterns of dual RB and p53 pathway inactivation in melanoma. G Yang A Rajadurai H Tsao, J Invest Dermatol 2005 125 6 1242 1251 10.1111/j.0022-202X.2005.23931.x 16354195
19. Protein Therapy: in vivo protein transduction by polyarginine (11R) PTD and subcellular targeting delivery. H Matsui K Tomizawa YF Lu M Matsushita, Curr Protein Pept Sci 2003 4 2 151 157 10.2174/1389203033487270 12678854
20. Therapeutic benefits of intrathecal protein therapy in a mouse model of amyotrophic lateral sclerosis. Y Ohta T Kamiya M Nagai T Nagata N Morimoto K Miyazaki T Murakami T Kurata Y Takehisa Y Ikeda S Asoh S Ohta K Abe, J Neurosci Res 2008 86 13 3028 3037 10.1002/jnr.21747 18543336
21. Anti-apoptotic therapy with a Tat fusion protein protects against excitotoxic insults in vitro and in vivo. KL Ju NC Manley RM Sapolsky, Exp Neurol 2008 210 2 602 607 10.1016/j.expneurol.2007.12.008 18207142
22. The exogenous wild-type p14ARF gene induces growth arrest and promotes radiosensitivity in human lung cancer cell lines. N Gao YD Hu XY Cao J Zhou SL Cao, J Cancer Res Clin Oncol 2001 127 6 359 367 10.1007/s004320000184 11414196
23. Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells. C Craig M Kim E Ohri R Wersto D Katayose Z Li YH Choi B Mudahar S Srivastava P Seth K Cowan, Oncogene 1998 16 2 265 272 10.1038/sj.onc.1201493 9464545
24. Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. W Arap R Nishikawa FB Furnari WK Cavenee HJ Huang, Cancer Res 1995 55 6 1351 1354 7882335
25. Growth inhibition of transfection of p16 gene to lung adenocarcinoma cell lines Anip973 and AGZY83-a. W Bai-qiu Y Cheng-hui G Hui F Song-bin L Pu, Chin J Lung Cancer 2001 4 6
26. Different effects of p16 gene on human glioma cell lines through different transfection methods. C Yi-zhao X Rui-xiang Z Shi-zhong Z Ling, Ai Zheng 2000 19 2 116 120
27. Transducible peptide therapy for uveal melanoma and retinoblastoma. JW Harbour L Worley D Ma M Cohen, Arch Ophthalmol 2002 120 10 1341 1346 12365913
28. In vivo protein transduction: delivery of a biologically active protein into the mouse. SR Schwarze A Ho A Vocero-Akbani SF Dowdy, Science 1999 285 5433 1569 1572 10.1126/science.285.5433.1569 10477521
29. PTD4-apoptin protein therapy inhibits tumor growth in vivo. J Sun Y Yan XT Wang XW Liu DJ Peng M Wang J Tian YQ Zong YH Zhang MH Noteborn S Qu, Int J Cancer 2009 124 12 2973 2981 10.1002/ijc.24279 19326452